China’s biotech firms move up value chain as drug deals evolve beyond licensing: analysts

South China Morning Post26 September 2026, 01:00 UTCPeople's Republic of China

Chinese biotech deal making is moving beyond the licensing of individual drug candidates, as the country transforms from a follower to a global innovation leader, according to analysts. The latest transaction underscores that shift. Beijing-based cancer drug developer InnoCare Pharma said on Thursday that it had entered into a strategic research collaboration and licensing agreement with US pharmaceutical giant Eli Lilly that could be worth up to US$3.35 billion. InnoCare said it would use its...

Read the full story at South China Morning Post Open in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about People's Republic of China

After a yearslong slump, China's real estate market may be set for a turnaroundCNBC8 October 2026, 09:27 UTCPeople's Republic of ChinaA recovery in China's largest cities real estate markets could come as soon as next year, the S&P ratings agency said.
Uniqlo sees profits soar in China despite Beijing-Tokyo tensionsSouth China Morning Post8 October 2026, 09:15 UTCPeople's Republic of ChinaFast Retailing, the parent company of Japanese clothing retailer Uniqlo, has defied the ongoing political tensions between Beijing and Tokyo and soft consumer sentiment in China to log a rebound in...
Trump pushed Xi to end Japan freeze, but Chinese leader unmovedSouth China Morning Post8 October 2026, 09:11 UTCPeople's Republic of ChinaGovernment leadersUS President Donald Trump pressed Chinese counterpart Xi Jinping during last month’s summit to end a deep freeze in relations with Japan’s Sanae Takaichi, the South China Morning Post reported. Tru...
China’s AI chipmaker Biren tumbles 12% as it seeks US$510 million in share placementSouth China Morning Post8 October 2026, 08:31 UTCPeople's Republic of ChinaStock marketShares of artificial intelligence chipmaker Shanghai Biren Technology tumbled more than 12 per cent in Hong Kong on Thursday amid plans to raise HK$4 billion (US$510 million) through a share placem...
China has nominated health official Song Li as WHO head - ReutersReuters8 October 2026, 08:17 UTCPeople's Republic of ChinaChina has nominated health official Song Li as WHO head Reuters
Chinese team says its all-in-one mini artificial pancreas offers next-gen diabetes careSouth China Morning Post8 October 2026, 08:00 UTCPeople's Republic of ChinaChinese scientists have created a wearable all-in-one device combining a glucose sensor and insulin micropump that they say paves the way for a fully autonomous mini artificial pancreas, although i...
Handelsconfrontatie dreigt: ‘supercruciale’ ontmoeting EU en ChinaNOS8 October 2026, 07:40 UTCPeople's Republic of ChinaLeader meetingsPeking is vandaag en morgen het decor van een ontmoeting tussen de Europese Unie en China. Na maanden van oplopende spanningen over de onderlinge handel, ontmoet Eurocommissaris van Handel Sefcovic...
US AI firm Anthropic enables Chinese-language options for Claude chatbotSouth China Morning Post8 October 2026, 07:38 UTCPeople's Republic of ChinaUS artificial intelligence company Anthropic has introduced Chinese-language options to its Claude chatbot in supported markets, even as it continues to block users from mainland China. Checks by t...